Development of Graves orbitopathy after thyroidectomy for thyroid cancer. [PDF]
Hormiz M +5 more
europepmc +1 more source
Efficacy and safety of tocilizumab in the treatment of Graves' orbitopathy: a systematic review and meta-analysis. [PDF]
Chen J, Chen Y, Huang H, Duan H.
europepmc +1 more source
Assessment of disease activity in Graves' orbitopathy. [PDF]
Potvin ARGG +5 more
europepmc +1 more source
Unilateral proptosis as the manifestation of euthyroid Graves orbitopathy: A case report. [PDF]
Rauniyar S +4 more
europepmc +1 more source
Complications after radiotherapy in patients with Graves' orbitopathy: A nationwide cohort study. [PDF]
Lee J, Ahn HY, Heo JS, Kim M, Lee JK.
europepmc +1 more source
Selenium Supplementation in Graves' Orbitopathy: Effects on Blood Concentrations and Clinical Outcomes. [PDF]
Lumyongsatien M +5 more
europepmc +1 more source
Graves’ Orbitopathy and Oxidative Stress [PDF]
C. Novembrino +4 more
openaire +3 more sources
Dysthyroid Optic Neuropathy in Graves' Orbitopathy: Insights from a Single Centre and Limitations of the Radiological Indices. [PDF]
Agarwal K +12 more
europepmc +1 more source
Unravelling the pathogenic mechanisms in Graves' orbitopathy. [PDF]
Lee ACH, Kahaly GJ.
europepmc +1 more source
Sarilumab in the management of Graves orbitopathy with low clinical activity scores. [PDF]
Pérez-Moreiras J +3 more
europepmc +1 more source

